Key result
Biomarkers play an evolving role in the clinical monitoring and prognosis of CAD.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support biomarker-guided CAD monitoring; leaves open need for prospective validation before practice change.
Coronary artery
No takes yet. Share an insight, caveat, or question.
Vikrant Rai (2025) studied this question. Biomarkers have an evolving current and future role in the clinical monitoring and prognostic assessment of patients with coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: